Discover how Anneo Biotech is quietly leading India's probiotic revolution, building the future of preventive healthcare.

India’s Glenmark is rolling all of the new molecular entities (NMEs) in its pipeline into a separate U.S. company in an effort to speed the programs to market. Glenmark says all its preclinical and ...

BENAKENAKONDA, India --Here, under a blazing sun in a southern Indian cotton field 9,000 miles from U.S. biotechnology giant Monsanto's headquarters, Chikkappa Nilakanti has literally sown seeds of ...

Tight global capital flows and gaps at home push startups to look abroad ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

@JohnCFierce: Big Pharma knows it has a huge development problem, but I don't buy the we'll-act-like-biotechs-from-now-on routine. | Follow @JohnCFierce > India's cancer-drug market, valued at about ...

The Indian government has unveiled bold plans to rekindle its homegrown biotech industry, allocating Rs. 24 billion ($372 million) for 2018–2019, the Department of Biotechnology (DBT) announced on ...

When Mitra Biotech’s founders decided to shift from the U.S. to India, where they were confident they had a technological advantage in developing personalized cancer care for patients, private equity ...

BENGALURU, Feb 18 (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40 countries, the company told Reuters ...